Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families

被引：70

作者：

Kauff, ND

Perez-Segura, P

Robson, ME

Scheuer, L

Siegel, B

Schluger, A

Rapaport, B

Frank, TS

Nafa, K

Ellis, NA

Parmigiani, G

Offit, K

机构：

[1] Mem Sloan Kettering Canc Ctr, Clin Genet Serv, Dept Med, New York, NY 10021 USA

[2] San Carlos Univ Hosp, Dept Med Oncol, Madrid, Spain

[3] Myriad Genet Labs, Salt Lake City, UT USA

[4] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA

[5] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA

来源：

JOURNAL OF MEDICAL GENETICS | 2002年 / 39卷 / 08期

关键词：

D O I：

10.1136/jmg.39.8.611

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

页码：611 / 614

页数：4

共 37 条

[1]

Berman DB, 1996, AM J HUM GENET, V58, P1166

[2] BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes [J].

Berry, DA ;

Iversen, ES ;

Gudbjartsson, DF ;

Hiller, EH ;

Garber, JE ;

Peshkin, BN ;

Lerman, C ;

Watson, P ;

Lynch, HT ;

Hilsenbeck, SG ;

Rubinstein, WS ;

Hughes, KS ;

Parmigiani, G .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) :2701-2712

[3] Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history [J].

Berry, DA ;

Parmigiani, G ;

Sanchez, J ;

Schildkraut, J ;

Winer, E .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (03) :227-238

[4] BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer [J].

Couch, FJ ;

DeShano, ML ;

Blackwood, MA ;

Calzone, K ;

Stopfer, J ;

Campeau, L ;

Ganguly, A ;

Rebbeck, T ;

Weber, BL ;

Jablon, L ;

Cobleigh, MA ;

Hoskins, K ;

Garber, JE .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (20) :1409-1415

[5]

Davidson A. C., 1997, BOOTSTRAP METHODS TH

[6] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].

Ford, D ;

Easton, DF ;

Stratton, M ;

Narod, S ;

Goldgar, D ;

Devilee, P ;

Bishop, DT ;

Weber, B ;

Lenoir, G ;

Chang-Claude, J ;

Sobol, H ;

Teare, MD ;

Struewing, J ;

Arason, A ;

Scherneck, S ;

Peto, J ;

Rebbeck, TR ;

Tonin, P ;

Neuhausen, S ;

Barkardottir, R ;

Eyfjord, J ;

Lynch, H ;

Ponder, BAJ ;

Gayther, SA ;

Birch, JM ;

Lindblom, A ;

Stoppa-Lyonnet, D ;

Bignon, Y ;

Borg, A ;

Hamann, U ;

Haites, N ;

Scott, RJ ;

Maugard, CM ;

Vasen, H .

AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689

[7] THE GENETICS OF BREAST AND OVARIAN-CANCER [J].

FORD, D ;

EASTON, DF .

BRITISH JOURNAL OF CANCER, 1995, 72 (04) :805-812

[8] Sequence analysis of BRCA1 and BRCA2:: Correlation of mutations with family history and ovarian cancer risk [J].

Frank, TS ;

Manley, SA ;

Olopade, OI ;

Cummings, S ;

Garber, JE ;

Bernhardt, B ;

Antman, K ;

Russo, D ;

Wood, ME ;

Mullineau, L ;

Isaacs, C ;

Peshkin, B ;

Buys, S ;

Venne, V ;

Rowley, PT ;

Loader, S ;

Offit, K ;

Robson, M ;

Hampel, H ;

Brener, D ;

Winer, EP ;

Clark, S ;

Weber, B ;

Strong, LC ;

Rieger, P ;

McClure, M ;

Ward, BE ;

Shattuck-Eidens, D ;

Oliphant, A ;

Skolnick, MH ;

Thomas, A .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) :2417-2425

[9] Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2:: Analysis of 10,000 individuals [J].

Frank, TS ;

Deffenbaugh, AM ;

Reid, JE ;

Hulick, M ;

Ward, BE ;

Lingenfelter, B ;

Gumpper, KL ;

Scholl, T ;

Tavtigian, SV ;

Pruss, DR ;

Critchfield, GC .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1480-1490

[10] High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families [J].

Ganguly, T ;

Dhulipala, R ;

Godmilow, L ;

Ganguly, A .

HUMAN GENETICS, 1998, 102 (05) :549-556

← 1 2 3 4 →